Literature DB >> 24982316

Adenovirus infections in immunocompetent and immunocompromised patients.

Thomas Lion1.   

Abstract

Human adenoviruses (HAdVs) are an important cause of infections in both immunocompetent and immunocompromised individuals, and they continue to provide clinical challenges pertaining to diagnostics and treatment. The growing number of HAdV types identified by genomic analysis, as well as the improved understanding of the sites of viral persistence and reactivation, requires continuous adaptions of diagnostic approaches to facilitate timely detection and monitoring of HAdV infections. In view of the clinical relevance of life-threatening HAdV diseases in the immunocompromised setting, there is an urgent need for highly effective treatment modalities lacking major side effects. The present review summarizes the recent progress in the understanding and management of HAdV infections.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24982316      PMCID: PMC4135893          DOI: 10.1128/CMR.00116-13

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  268 in total

1.  First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults.

Authors:  Hamid Jalal; David F Bibby; Julian W Tang; Julie Bennett; Chara Kyriakou; Karl Peggs; David Cubitt; Nicola S Brink; Kate N Ward; Richard S Tedder
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.

Authors:  M Tomblyn; T Chiller; H Einsele; R Gress; K Sepkowitz; J Storek; J R Wingard; J-A H Young; M J Boeckh
Journal:  Bone Marrow Transplant       Date:  2009-10       Impact factor: 5.483

3.  Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.

Authors:  Waseem Qasim; Sophie Derniame; Kimberly Gilmour; Robert Chiesa; Martin Weber; Stuart Adams; Kanchan Rao; Persis Amrolia; Nicholas Goulden; Paul Veys; Hubert Gaspar
Journal:  Br J Haematol       Date:  2011-04-19       Impact factor: 6.998

4.  Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis.

Authors:  J Y Hong; H J Lee; P A Piedra; E H Choi; K H Park; Y Y Koh; W S Kim
Journal:  Clin Infect Dis       Date:  2001-04-18       Impact factor: 9.079

5.  Identification of adenoviruses in specimens from high-risk pediatric stem cell transplant recipients and controls.

Authors:  Xiaotian Zheng; Xiaoyan Lu; Dean D Erdman; Evan J Anderson; Judith A Guzman-Cottrill; Morris Kletzel; Ben Z Katz
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

6.  Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.

Authors:  Ann M Leen; Uluhan Sili; Elio F Vanin; Alan M Jewell; Weidong Xie; Dario Vignali; Pedro A Piedra; Malcolm K Brenner; Cliona M Rooney
Journal:  Blood       Date:  2004-07-20       Impact factor: 22.113

7.  Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.

Authors:  Gregory C Gray; Troy McCarthy; Mark G Lebeck; David P Schnurr; Kevin L Russell; Adriana E Kajon; Marie L Landry; Diane S Leland; Gregory A Storch; Christine C Ginocchio; Christine C Robinson; Gail J Demmler; Michael A Saubolle; Sue C Kehl; Rangaraj Selvarangan; Melissa B Miller; James D Chappell; Danielle M Zerr; Deanna L Kiska; Diane C Halstead; Ana W Capuano; Sharon F Setterquist; Margaret L Chorazy; Jeffrey D Dawson; Dean D Erdman
Journal:  Clin Infect Dis       Date:  2007-09-27       Impact factor: 9.079

8.  Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.

Authors:  N Symeonidis; A Jakubowski; S Pierre-Louis; D Jaffe; E Pamer; K Sepkowitz; R J O'Reilly; G A Papanicolaou
Journal:  Transpl Infect Dis       Date:  2007-06       Impact factor: 2.228

9.  HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy.

Authors:  Geothy Chakupurakal; David Onion; Sarah Bonney; Mark Cobbold; Vivien Mautner; Paul Moss
Journal:  J Immunother       Date:  2013-10       Impact factor: 4.456

10.  Evidence of molecular evolution driven by recombination events influencing tropism in a novel human adenovirus that causes epidemic keratoconjunctivitis.

Authors:  Michael P Walsh; Ashish Chintakuntlawar; Christopher M Robinson; Ijad Madisch; Balázs Harrach; Nolan R Hudson; David Schnurr; Albert Heim; James Chodosh; Donald Seto; Morris S Jones
Journal:  PLoS One       Date:  2009-06-03       Impact factor: 3.240

View more
  229 in total

1.  DNA sense-and-respond protein modules for mammalian cells.

Authors:  Shimyn Slomovic; James J Collins
Journal:  Nat Methods       Date:  2015-09-21       Impact factor: 28.547

Review 2.  Genomic foundations of evolution and ocular pathogenesis in human adenovirus species D.

Authors:  Ashrafali Mohamed Ismail; Xiaohong Zhou; David W Dyer; Donald Seto; Jaya Rajaiya; James Chodosh
Journal:  FEBS Lett       Date:  2019-12-11       Impact factor: 4.124

Review 3.  Epigenetics and the dynamics of chromatin during adenovirus infections.

Authors:  Kelsey L Lynch; Linda R Gooding; Charlie Garnett-Benson; David A Ornelles; Daphne C Avgousti
Journal:  FEBS Lett       Date:  2019-12-15       Impact factor: 4.124

4.  Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.

Authors:  Yeon Joo Lee; Yao-Ting Huang; Seong Jin Kim; Molly Maloy; Roni Tamari; Sergio A Giralt; Esperanza B Papadopoulos; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-28       Impact factor: 5.742

5.  Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.

Authors:  Jeffrey M Chamberlain; Katherine Sortino; Phiroze Sethna; Andrew Bae; Randall Lanier; Robert A Bambara; Stephen Dewhurst
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

6.  Human adenovirus meningoencephalitis: a 3-years' overview.

Authors:  Luine Rosele Vidal; Sérgio Monteiro de Almeida; Bárbara Maria Cavalli; Tatiana Gutierrez Dieckmann; Sonia Mara Raboni; Gabriel L O Salvador; Luciane Aparecida Pereira; Indianara Rotta; Meri Bordignon Nogueira
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

Review 7.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation.

Authors:  Sook-Young Sohn; Patrick Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

9.  Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver.

Authors:  Andrea M Lerner; John E Bennett; Stefania Pittaluga; Pavel P Khil; J H Youn; Gary A Fahle; Karen M Frank; John P Dekker; Theresa D Jerussi; Clare Sun; Adrian Wiestner; Juan Gea-Banacloche
Journal:  Diagn Microbiol Infect Dis       Date:  2019-01-02       Impact factor: 2.803

10.  Longitudinal quantification of adenovirus neutralizing responses in Zambian mother-infant pairs: Impact of HIV-1 infection and its treatment.

Authors:  Sara R Privatt; Brianna L Bullard; Eric A Weaver; Charles Wood; John T West
Journal:  Vaccine       Date:  2019-08-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.